Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2014

Open Access 01-12-2014 | Case report

Sensory neuronopathy complicating systemic lupus erythematosus: a case report

Authors: Mitrakrishnan Rayno Navinan, Paramarajan Piranavan, Ali Uthuman Ali Akram, Jevon Yudhishdran, Thambyaiah Kandeepan, Aruna Kulatunga

Published in: Journal of Medical Case Reports | Issue 1/2014

Login to get access

Abstract

Introduction

Systemic lupus erythematosus is a multi-system connective tissue disorder. Peripheral neuropathy is a known and underestimated complication in systemic lupus erythematosus. Ganglionopathy manifests when neuronal cell bodies in the dorsal root ganglion are involved. Autoimmune disorders are a known etiology, with systemic lupus erythematosus being a rare cause.

Case presentation

A 32-year-old South Asian woman presented with oral ulceration involving her lips following initiation of treatment for a febrile illness associated with dysuria. She had a history of progressively worsening numbness over a period of 4 months involving both the upper and lower limbs symmetrically while sparing the trunk. Her vibration sense was impaired, and her reflexes were diminished. For the past 4 years, she had had a bilateral, symmetrical, non-deforming arthritis involving the upper and lower limbs. Her anti-nuclear antibody and anti-double-stranded deoxyribonucleic acid status were positive. Although her anti-Ro antibodies were positive, she did not have clinical features suggestive of Sjögren syndrome. Nerve conduction studies revealed sensory neuronopathy. A diagnosis of systemic lupus erythematosus complicated by sensory neuronopathy was made. Treatment with intravenous immunoglobulin resulted in clinical and electrophysiological improvement.

Conclusion

Peripheral neuropathy in systemic lupus erythematosus can, by itself, be a disabling feature. Nerve conduction studies should be considered when relevant. Neuropathy in systemic lupus erythematosus should be given greater recognition, and rarer forms of presentation should be entertained in the differential diagnosis when the clinical picture is atypical. Intravenous immunoglobulin may have role in treatment of sensory neuronopathy in systemic lupus erythematosus.
Appendix
Available only for authorised users
Literature
1.
go back to reference Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR: Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011, 41: 203-211.CrossRefPubMed Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR: Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011, 41: 203-211.CrossRefPubMed
2.
go back to reference Omdal R, Løseth S, Torbergsen T, Koldingsnes W, Husby G, Mellgren SI: Peripheral neuropathy in systemic lupus erythematosus—a longitudinal study. Acta Neurol Scand. 2001, 103: 386-391.CrossRefPubMed Omdal R, Løseth S, Torbergsen T, Koldingsnes W, Husby G, Mellgren SI: Peripheral neuropathy in systemic lupus erythematosus—a longitudinal study. Acta Neurol Scand. 2001, 103: 386-391.CrossRefPubMed
3.
go back to reference Goh KJ, Wang CL, Leong S, Tan CT: Peripheral neuropathy in systemic lupus erythematosus: electrophysiological features in 50 consecutive patients. Neurol J Southeast Asia. 1996, 1: 47-51. Goh KJ, Wang CL, Leong S, Tan CT: Peripheral neuropathy in systemic lupus erythematosus: electrophysiological features in 50 consecutive patients. Neurol J Southeast Asia. 1996, 1: 47-51.
4.
go back to reference Grantz M: Unusual peripheral neuropathies. Part II: intrinsic reactive causes. Semin Neurol. 2010, 30: 396-404.CrossRefPubMed Grantz M: Unusual peripheral neuropathies. Part II: intrinsic reactive causes. Semin Neurol. 2010, 30: 396-404.CrossRefPubMed
5.
go back to reference Wallace D, Hahn BH: Dubois’ Lupus Erythematosus and Related Syndromes. 2013, New York: Saunders/Elsevier Health Sciences, 8 Wallace D, Hahn BH: Dubois’ Lupus Erythematosus and Related Syndromes. 2013, New York: Saunders/Elsevier Health Sciences, 8
6.
go back to reference Saluja S, Kumar A, Khamashta M, Hughes GR, Malaviya AN: Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India. Indian J Med Res. 1990, 92: 224-227.PubMed Saluja S, Kumar A, Khamashta M, Hughes GR, Malaviya AN: Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India. Indian J Med Res. 1990, 92: 224-227.PubMed
7.
go back to reference Agarwal AK, Goel A, Rohtagi A, Dudeja RK, Kumar A, Kalra S: Acute inflammatory polyneuropathy in systemic lupus erythematosus. JIACM J Indian Acad Clin Med. 2005, 6: 334-336. Agarwal AK, Goel A, Rohtagi A, Dudeja RK, Kumar A, Kalra S: Acute inflammatory polyneuropathy in systemic lupus erythematosus. JIACM J Indian Acad Clin Med. 2005, 6: 334-336.
8.
go back to reference Donofrio PD: Textbook of Peripheral Neuropathy. 2012, New York: Demos Medical Publishing, 1 Donofrio PD: Textbook of Peripheral Neuropathy. 2012, New York: Demos Medical Publishing, 1
9.
go back to reference Wang JC, Lin YC, Yang TF, Lin HY: Ataxic sensory neuronopathy in a patient with systemic lupus erythematosus. Lupus. 2012, 21: 905-909.CrossRefPubMed Wang JC, Lin YC, Yang TF, Lin HY: Ataxic sensory neuronopathy in a patient with systemic lupus erythematosus. Lupus. 2012, 21: 905-909.CrossRefPubMed
10.
go back to reference Chad DA, Stone JH, Gupta R: Case records of the Massachusetts General Hospital. Case 14—2011: A woman with asymmetric sensory loss and paresthesias. N Engl J Med. 2011, 364: 1856-1865.CrossRefPubMed Chad DA, Stone JH, Gupta R: Case records of the Massachusetts General Hospital. Case 14—2011: A woman with asymmetric sensory loss and paresthesias. N Engl J Med. 2011, 364: 1856-1865.CrossRefPubMed
11.
go back to reference Camdessanché JP, Jousserand G, Ferraud K, Vial C, Petiot P, Honnorat J, Antoine JC: The pattern and diagnostic criteria of sensory neuronopathy: a case–control study. Brain. 2009, 132: 1723-1733.CrossRefPubMedPubMedCentral Camdessanché JP, Jousserand G, Ferraud K, Vial C, Petiot P, Honnorat J, Antoine JC: The pattern and diagnostic criteria of sensory neuronopathy: a case–control study. Brain. 2009, 132: 1723-1733.CrossRefPubMedPubMedCentral
12.
go back to reference Martinez ARM, Nunes MB, Nucci A, França MC: Sensory neuronopathy and autoimmune diseases. Autoimmune Dis. 2012, 2012: 873587-PubMedPubMedCentral Martinez ARM, Nunes MB, Nucci A, França MC: Sensory neuronopathy and autoimmune diseases. Autoimmune Dis. 2012, 2012: 873587-PubMedPubMedCentral
13.
go back to reference Kuntzer T, Antoine JC, Steck AJ: Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve. 2004, 30: 255-268.CrossRefPubMed Kuntzer T, Antoine JC, Steck AJ: Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve. 2004, 30: 255-268.CrossRefPubMed
14.
go back to reference Danieli MG, Pettinari L, Morariu R, Monteforte F, Logullo F: Intravenous immunoglobulin and mycophenolate mofetil for long-standing sensory neuronopathy in Sjögren’s syndrome. Case Rep Immunol. 2012, 2012: 186320- Danieli MG, Pettinari L, Morariu R, Monteforte F, Logullo F: Intravenous immunoglobulin and mycophenolate mofetil for long-standing sensory neuronopathy in Sjögren’s syndrome. Case Rep Immunol. 2012, 2012: 186320-
15.
go back to reference Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J. 1965, 14: 61-65.PubMed Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J. 1965, 14: 61-65.PubMed
16.
go back to reference Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C: Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain. 2007, 130: 1076-1088.CrossRefPubMed Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C: Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain. 2007, 130: 1076-1088.CrossRefPubMed
17.
go back to reference Xu Y, Sladky JT, Brown MJ: Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology. 1989, 39: 1077-1083.CrossRefPubMed Xu Y, Sladky JT, Brown MJ: Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology. 1989, 39: 1077-1083.CrossRefPubMed
18.
go back to reference Basavaraju N, Ahmad M, Slattery E: Dorsal root ganglionopathy in a hepatitis C patient: a case report. Ann Hepatol. 2012, 11: 958-960.PubMed Basavaraju N, Ahmad M, Slattery E: Dorsal root ganglionopathy in a hepatitis C patient: a case report. Ann Hepatol. 2012, 11: 958-960.PubMed
19.
go back to reference Scaravilli F, Sinclair E, Arango JC, Manji H, Lucas S, Harrison MJ: The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol. 1992, 84: 163-170.CrossRefPubMed Scaravilli F, Sinclair E, Arango JC, Manji H, Lucas S, Harrison MJ: The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol. 1992, 84: 163-170.CrossRefPubMed
20.
go back to reference Rubin DI, Daube JR: Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle Nerve. 1999, 22: 1607-1610.CrossRefPubMed Rubin DI, Daube JR: Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle Nerve. 1999, 22: 1607-1610.CrossRefPubMed
21.
go back to reference Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grünewald RA, Davies-Jones AG: Sensory ganglionopathy due to gluten sensitivity. Neurology. 2010, 75: 1003-1008.CrossRefPubMed Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grünewald RA, Davies-Jones AG: Sensory ganglionopathy due to gluten sensitivity. Neurology. 2010, 75: 1003-1008.CrossRefPubMed
22.
go back to reference Merchut MP, Adams EM, Morrissey M: Sensory neuronopathy in autoimmune chronic active hepatitis. Neurology. 1993, 43: 2410-2411.CrossRefPubMed Merchut MP, Adams EM, Morrissey M: Sensory neuronopathy in autoimmune chronic active hepatitis. Neurology. 1993, 43: 2410-2411.CrossRefPubMed
23.
go back to reference Lauria G, Pareyson D, Sghirlanzoni A: Neurophysiological diagnosis of acquired sensory ganglionopathies. Eur Neurol. 2003, 50: 146-152.CrossRefPubMed Lauria G, Pareyson D, Sghirlanzoni A: Neurophysiological diagnosis of acquired sensory ganglionopathies. Eur Neurol. 2003, 50: 146-152.CrossRefPubMed
24.
go back to reference Majid A, Galetta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, Forghani B, Gilden DH: Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain. 2002, 125: 159-165.CrossRefPubMed Majid A, Galetta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, Forghani B, Gilden DH: Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain. 2002, 125: 159-165.CrossRefPubMed
25.
go back to reference Amato AA, Dumitru D: Acquired neuropathies. Electrodiagnostic Medicine. 2002, Philadelphia, PA: Hanley & Belfus, 937-1041. 2 Amato AA, Dumitru D: Acquired neuropathies. Electrodiagnostic Medicine. 2002, Philadelphia, PA: Hanley & Belfus, 937-1041. 2
26.
go back to reference Gorson KC, Natarajan N, Ropper AH, Weinstein R: Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve. 2007, 35: 66-69.CrossRefPubMed Gorson KC, Natarajan N, Ropper AH, Weinstein R: Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve. 2007, 35: 66-69.CrossRefPubMed
27.
go back to reference Caroyer JM, Manto MU, Steinfeld SD: Severe sensory neuronopathy responsive to infliximab in primary Sjögren’s syndrome. Neurology. 2002, 59: 1113-1114.CrossRefPubMed Caroyer JM, Manto MU, Steinfeld SD: Severe sensory neuronopathy responsive to infliximab in primary Sjögren’s syndrome. Neurology. 2002, 59: 1113-1114.CrossRefPubMed
28.
go back to reference Schaller B, Radziwill AJ, Steck AJ: Successful treatment of Guillain-Barré syndrome with combined administration of interferon-β-1a and intravenous immunoglobulin. Eur Neurol. 2001, 46: 167-168.CrossRefPubMed Schaller B, Radziwill AJ, Steck AJ: Successful treatment of Guillain-Barré syndrome with combined administration of interferon-β-1a and intravenous immunoglobulin. Eur Neurol. 2001, 46: 167-168.CrossRefPubMed
29.
go back to reference Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I: Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren’s syndrome. IV. Immunoglobulin. Neurology. 2003, 60: 503-505.CrossRefPubMed Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I: Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren’s syndrome. IV. Immunoglobulin. Neurology. 2003, 60: 503-505.CrossRefPubMed
Metadata
Title
Sensory neuronopathy complicating systemic lupus erythematosus: a case report
Authors
Mitrakrishnan Rayno Navinan
Paramarajan Piranavan
Ali Uthuman Ali Akram
Jevon Yudhishdran
Thambyaiah Kandeepan
Aruna Kulatunga
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-8-141

Other articles of this Issue 1/2014

Journal of Medical Case Reports 1/2014 Go to the issue